Pharmaceutical giant Merck, which operates as MSD outside of the U.S., is to acquire the WuXi Vaccines manufacturing plant in Dundalk as part of a €500M deal, bringing the U.S.-based company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback